Your browser doesn't support javascript.
loading
The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.
Huang, Jee-Fu; Yu, Ming-Lung; Huang, Chung-Feng; Chiu, Chang-Fu; Dai, Chia-Yen; Huang, Ching-I; Yeh, Ming-Lun; Yang, Jeng-Fu; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long.
Afiliação
  • Huang JF; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
J Hepatol ; 54(2): 219-26, 2011 Feb.
Article em En | MEDLINE | ID: mdl-21056500

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Ribavirina / Interferon-alfa / Carcinoma Hepatocelular / Hepatite C Crônica / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Polietilenoglicóis / Ribavirina / Interferon-alfa / Carcinoma Hepatocelular / Hepatite C Crônica / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article